Evidence that abnormalities of central neurohormonal systems are key to understanding fibromyalgia and chronic fatigue syndrome (Q41154370)

27 September 2017

1 reference

title

Evidence that abnormalities of central neurohormonal systems are key to understanding fibromyalgia and chronic fatigue syndrome (English)

1 reference

27 September 2017

0 references

1

Crofford LJ

1 reference

27 September 2017

Demitrack MA

2

1 reference

27 September 2017

1 May 1996

1 reference

Rheumatic Diseases Clinics of North America

27 September 2017

1 reference

27 September 2017

22

1 reference

27 September 2017

2

1 reference

27 September 2017

267-284

1 reference

Neuropeptide Y Distribution in the Rat Brain

27 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Abnormal arginine-vasopressin secretion and water metabolism in patients with postviral fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

The "chronic, active Epstein-Barr virus infection" syndrome and primary fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Hypothalamic receptors influencing the secretion of corticotrophin releasing hormone in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Hippocampal 8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding site densities, serotonin receptor (5-HT1A) messenger ribonucleic acid abundance, and serotonin levels parallel the activity of the hypothalamopituitary-adrenal axis in rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Clinical characteristics of fibrositis. II. A "blinded," controlled study using standard psychological tests

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Contrasting neuroendocrine responses in depression and chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Corticosteroids and the control of function in the hypothalamo-pituitary-adrenal (HPA) axis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Stress, feedback and facilitation in the hypothalamo-pituitary-adrenal axis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Plasma and cerebrospinal fluid monoamine metabolism in patients with chronic fatigue syndrome: Preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system--II. Immunohistochemical analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Do patients with primary fibromyalgia have an altered muscle sympathetic nerve activity?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity: lack of effect in other rat brain regions.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Paradoxical responses of hypothalamic corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proopiomelanocortin mRNA during chronic inflammatory stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

The psychiatric status of patients with the chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Role of serotonin in the control of secretion of corticotrophin releasing factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Comorbidity of fibromyalgia with medical and psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Brucellosis. III. Psychologic aspects of delayed convalescence.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Effect on various putative neurotransmitters on the secretion of corticotrophin-releasing hormone from the rat hypothalamus in vitro-a model of the neurotransmitters involved

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Abnormal pituitary-adrenal responses to corticotropin-releasing hormone in patients with seasonal affective disorder: clinical and pathophysiological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Cerebrospinal Fluid Immunoreactive Cortieotropin-Releasing Hormone and Adrenocorticotropin Secretion in Cushing's Disease and Major Depression: Potential Clinical Implications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Regulation of the hypothalamo-pituitary axis by neuropeptide Y.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Serotonin mediation of circadian periodicity of plasma 17-hydroxycorticosteroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Neuropeptide Y and sympathetic neurotransmission

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Depression among patients with a chief complaint of chronic fatigue.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Individual differences in the hypothalamic-pituitary-adrenal stress response and the hypothalamic CRF system

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Environmental regulation of the development of glucocorticoid receptor systems in the rat forebrain. The role of serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Plasma tryptophan and musculoskeletal pain in non-articular rheumatism (“fibrositis syndrome”)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Increased plasma concentrations, hypothalamic content, and in vitro release of arginine vasopressin in inflammatory disease-prone, hypothalamic corticotropin-releasing hormone-deficient Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Increased arginine vasopressin secretion may participate in the enhanced susceptibility of Lewis rats to inflammatory disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Disrupted 24-hour Patterns of Cortisol Secretion in Psychotic Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Glucocorticoid feedback inhibition of adrenocorticotropic hormone secretagogue release. Relationship to corticosteroid receptor occupancy in various limbic sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Chronic activation of the hypothalamo-pituitary-adrenal axis and loss of circadian rhythm during adjuvant-induced arthritis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Relation of Brain 5-Hydroxytryptamine Content to the Diurnal Variation in Plasma Corticosterone in the Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Neonatal endotoxin exposure alters the development of the hypothalamic-pituitary-adrenal axis: early illness and later responsivity to stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

What is chronic brucellosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Corticotropin releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Corticotropin releasing factor produces behavioural activation in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Immunoreactive corticotropin-releasing factor concentrations in cerebrospinal fluid from patients with hypothalamic-pituitary-adrenal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Corticotropin-releasing factor: evidence for a neurotransmitter role in the locus ceruleus during hemodynamic stress

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Fibromyalgia and menopause. Examination of the relationship.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

A Role for Serotonin in the Hypothalamic-Pituitary-Adrenal Response to Insulin Stress

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Dissociation between pituitary and adrenal suppression to dexamethasone in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970272-6

7 January 2021

10.1016/S0889-857X(05)70272-6

Identifiers

DOI

1 reference

27 September 2017

1 reference

PubMed ID

8860799